Zealand Pharma appoints new Chief Operating Officer
Zealand Pharma (ZEAL) announces the appointment of Agneta Svedberg as the company’s new Chief Operating Officer. Effective from 1 February 2013, she will join the Executive Management team to replace Senior Vice President and COO, John Hyttel, one of the founders of Zealand Pharma, who is now retiring after having worked with the company since its inception in 1998.
Agneta Svedberg (Swedish, born 1963) joins Zealand Pharma from Cantargia AB, a Swedish biotech company, where she has held a position as Chief Executive Officer. Agneta has more than 20 years of experience in drug development from different leadership functions in both biotech and big pharma companies, including more than ten years with Genmab A/S in Copenhagen, where she was Global Head of Clinical Development and held various senior management positions, the last year as Copenhagen site Manager with responsibility for 200 people. Prior to this, she was Head of Clinical Development (Europe) at Oxigene Europe AB and also held managerial positions at Pharmacia & Upjohn AB in Sweden. Agneta Svedberg holds a M.Sc. in Radiation Physics from Lund University and an Executive MBA from Lund University School of Economics and Management, Sweden.
Other news from the department people
